Decoded: Why India’s $130 billion pharma ambition faces a hurdle as investigation backlogs delay drug batch releases
A Vector Consulting Group study finds that 80% of surveyed pharmaceutical manufacturing professionals reported batch-release delays due to open investigations, highlighting how incident backlogs, documentation requirements and...





.jpg?width=1200&auto=webp&crop=3%3A2)







